Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 13, 2017 - Issue 7
Submit an article Journal homepage
2,037
Views
0
CrossRef citations to date
0
Altmetric
Research Papers

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa

Timo VesikariVaccine Research Center, University of Tampere, Tampere, FinlandCorrespondence[email protected]
,
Luis RiveraHospital Maternidad Nuestra Señora de la Altagracia Santo Domingo, Santo Domingo, Dominican Republic
,
Tiina KorhonenUniversity of Tampere, Tampere Vaccine Research Clinic, Tampere, Finland
,
Anitta AhonenVaccine Research Center, University of Tampere, Järvenpää Vaccine Clinic, Järvenpää, Finland
,
Brigitte CheuvartGSK, Wavre, Belgium
,
Marjan HezarehChiltern International c/o GSK, Wavre, Belgium
,
Winnie JanssensGSK, Wavre, Belgium
&
Narcisa MesarosGSK, Wavre, Belgium
 show all
Pages 1505-1515 | Received 15 Dec 2016, Accepted 08 Feb 2017, Published online: 24 Mar 2017

References

  • Maman K, Zollner Y, Greco D, Duru G, Sendyona S, Remy V. The value of childhood combination vaccines: from beliefs to evidence. Hum Vaccin Immunother 2015; 11(9):2132-41; PMID:26075806; https://doi.org/10.1080/21645515.2015.1044180
  • Skibinski DA, Baudner BC, Singh M, O'Hagan DT. Combination vaccines. J Global Infect Dis 2011; 3(1):63-72; https://doi.org/10.4103/0974-777X.77298
  • Agency EM. EPAR summary for the public: Infanrix hexa. [accessed 2016 Aug 3]. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR - Summary for the public/human/000296/WC500032499.pdf
  • Marshall GS, Adams GL, Leonardi ML, Petrecz M, Flores SA, Ngai AL, Xu J, Liu G, Stek JE, Foglia G, et al. Immunogenicity, safety, and tolerability of a hexavalent vaccine in infants. Pediatrics 2015; 136(2):e323-32; PMID:26216331; https://doi.org/10.1542/peds.2014-4102
  • Zepp F, Schmitt HJ, Cleerbout J, Verstraeten T, Schuerman L, Jacquet JM. Review of 8 years of experience with Infanrix hexa (DTPa–HBV–IPV/Hib hexavalent vaccine). Expert Rev Vaccines 2009; 8(6):663-78; https://doi.org/10.1586/erv.09.32
  • Lalwani SK, Agarkhedkar S, Sundaram B, Mahantashetti NS, Malshe N, Agarkhedkar S, Van Der Meeren O, Mehta S, Karkada N, Han HH, et al. Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants. Hum Vaccin Immunother 2017; 13(1):120-7; PMID:27629913; https://doi.org/10.1080/21645515.2016.1225639
  • Storsaeter J, Wolter J. Is there a need for a new generation of vaccines against pertussis? Expert Opin Emerg Drugs 2006; 11(2):195-205; PMID:16634696; https://doi.org/10.1517/14728214.11.2.195
  • Esposito S, Principi N. Impacts of the 13-valent pneumococcal conjugate vaccine in children. J Immunol Res 2015; 2015:591580; PMID:26351648
  • Schmitt HJ, Schuind A, Knuf M, Beutel K, Schulte-Wissermann H, Gahr M, Schult R, Folkens J, Rauh W, Bogaerts H, et al. Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. J Pediatr 1996; 129(5):695-701; PMID:8917236; https://doi.org/10.1016/S0022-3476(96)70152-X
  • Schmitt H-J, Müschenborn S, Wagner S, Knuf M, Bock HL, Bogaerts H, Clemens R. Immunogenicity and Reactogenicity of a Bicomponent and a Tricomponent Acellular Pertussis-Diphtheria-Tetanus (DTaP) vaccine in primary immunization and as second year booster: A double-blind, randomized trial. Int J Infect Dis 1996; 1(1):6-13; https://doi.org/10.1016/S1201-9712(96)90070-3
  • World Health Organisation (WHO). Standard Procedure for Determining Immunity to Poliovirus using the Microneutralisation Test (WHO/EPI/GEN 93.9) 1993. [accessed 2016 Nov 13]. http://apps.who.int/iris/bitstream/10665/70486/1/WHO_EPI_GEN_93.9_eng.pdf
  • Käyhty H, Peltola H, Karanko V, Mäkelä PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983; 147(6):1100; PMID:6602191; https://doi.org/10.1093/infdis/147.6.1100
  • Peltola H, Käythy H, Sivonen A, Mäkelä PH. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 1977; 60(5):730-37; PMID:335348
  • Centre for Disease Control (CDC). Hepatitis B Virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunisation Practices Advisory Committee (ACIP). MMWR 1991; 40(RR-13):1-19
  • World Health Organisation (WHO). Progress in the control of viral hepatitis: memorandum for a WHO meeting. Bull WHO 1988; 66:443-45; PMID:2971466

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.